Our Radiation Protection Policy Is A Hazard To Public Health

Where public-health policy is concerned, it makes sense to be conservative. But when we try too hard, we may actually do more harm than good. An egregious example is our policy on low-level ionizing radiation, primarily gamma rays and neutrons. Regulations are based on the premise that any amount of radiation, however small, must be considered hazardous. This premise was not derived scientifically, and the policy based on it is not conservative but is actually detrimental to public health. Il

Written byTheodore Rockwell
| 7 min read

Register for free to listen to this article
Listen with Speechify
0:00
7:00
Share

Where public-health policy is concerned, it makes sense to be conservative. But when we try too hard, we may actually do more harm than good. An egregious example is our policy on low-level ionizing radiation, primarily gamma rays and neutrons. Regulations are based on the premise that any amount of radiation, however small, must be considered hazardous. This premise was not derived scientifically, and the policy based on it is not conservative but is actually detrimental to public health.

Illustration: John Overmeyer Fear of harmless amounts of radiation has created situations that are directly inimical to health. Examples: More than 100,000 European women chose to have unnecessary abortions after the Chernobyl accident out of a groundless fear of bearing "nuclear mutants." Thousands of people die needlessly each year from pathogens infecting beef, poultry, eggs, and seafood that could easily be sterilized by irradiation. Thousands more die each year from breathing ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies